digital health tools glp-1 weight management Impact of Engagement on Loss Outcomes in Obesity Among Individuals Using and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study Dynamic GLP1 - GLP-1 Supplement

Its a textbook case of building a treatment ladder to maximize patient reach and lifetime value-watching this unfold will be fascinating.

New indications and more players in the field The number of indications for GLP-1s continues to grow steadily, like Ozempics recent approval for adults with type 2 diabetes and chronic kidney disease, as well as benefits beyond weight and blood sugar management (e.g., peripheral artery disease, liver disease, heart disease , sleep apnea, osteoarthritis)

Appetite, food intake and gut hormone responses to intense aerobic exercise of different duration

PMID: 33068776

This complexity has led many patients and clinicians to explore adjunctive weight loss therapies, including newer injectable medications